Benitec Biopharma Inc.
BNTC
$11.50
-$0.18-1.54%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | 0.00 | -3.00K |
| Gross Profit | -- | -- | -- | 0.00 | 3.00K |
| SG&A Expenses | 31.67M | 29.54M | 25.32M | 13.87M | 11.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.54M | 47.97M | 43.96M | 32.33M | 26.29M |
| Operating Income | -50.54M | -47.97M | -43.96M | -32.33M | -26.29M |
| Income Before Tax | -46.30M | -44.02M | -40.11M | -28.69M | -23.61M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -46.30 | -44.02 | -40.11 | -28.69 | -23.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -46.30M | -44.02M | -40.11M | -28.69M | -23.61M |
| EBIT | -50.54M | -47.97M | -43.96M | -32.33M | -26.29M |
| EBITDA | -50.49M | -47.92M | -43.89M | -32.25M | -26.20M |
| EPS Basic | -1.11 | -1.11 | -1.07 | -0.86 | -0.85 |
| Normalized Basic EPS | -0.69 | -0.70 | -0.68 | -0.55 | -0.55 |
| EPS Diluted | -1.11 | -1.11 | -1.07 | -0.86 | -0.85 |
| Normalized Diluted EPS | -0.69 | -0.70 | -0.68 | -0.55 | -0.55 |
| Average Basic Shares Outstanding | 167.25M | 158.53M | 144.90M | 129.57M | 109.25M |
| Average Diluted Shares Outstanding | 167.25M | 158.53M | 144.90M | 129.57M | 109.25M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |